Does TENAPANOR Cause Off label use? 94 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 94 reports of Off label use have been filed in association with TENAPANOR (IBSRELA). This represents 4.9% of all adverse event reports for TENAPANOR.
94
Reports of Off label use with TENAPANOR
4.9%
of all TENAPANOR reports
4
Deaths
34
Hospitalizations
How Dangerous Is Off label use From TENAPANOR?
Of the 94 reports, 4 (4.3%) resulted in death, 34 (36.2%) required hospitalization.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TENAPANOR. However, 94 reports have been filed with the FAERS database.
What Other Side Effects Does TENAPANOR Cause?
Diarrhoea (793)
Death (222)
Hospitalisation (138)
Inappropriate schedule of product administration (115)
Product use issue (72)
Nausea (59)
Abdominal distension (52)
Therapy interrupted (52)
Abdominal pain (50)
Product use in unapproved indication (47)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which TENAPANOR Alternatives Have Lower Off label use Risk?
TENAPANOR vs TENECTEPLASE
TENAPANOR vs TENELIGLIPTIN
TENAPANOR vs TENIPOSIDE
TENAPANOR vs TENOFOVIR
TENAPANOR vs TENOFOVIR ALAFENAMIDE